|
|
Volumn 18, Issue SUPPL.F, 1997, Pages
|
|
Targeting new thrombolytic regimens at specific patient groups: Implications for research and cost-containment
a
|
|
Author keywords
Acute myocardial infarction; New approach; Patient selection; Thrombolysis
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
FIBRINOLYTIC AGENT;
STREPTOKINASE;
ACUTE HEART INFARCTION;
CLINICAL TRIAL;
CONFERENCE PAPER;
CORONARY REPERFUSION;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DRUG TARGETING;
FIBRINOLYTIC THERAPY;
HUMAN;
MORTALITY;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
TREATMENT OUTCOME;
TREATMENT PLANNING;
|
|
EID: 0030782568
PISSN: 0195668X
EISSN: None
Source Type: Journal
DOI: 10.1093/eurheartj/18.suppl_f.28 Document Type: Conference Paper |
|
Times cited : (5)
|
|
References (44)
|
